Page last updated: 2024-10-29

indomethacin and Abnormality, Heart

indomethacin has been researched along with Abnormality, Heart in 35 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
" These factors (immaturity, hyperoxia, hypoxia, blood transfusions, intraventricular hemorrhage, apnea, infection, hypercarbia, hypocarbia, patent ductus arteriosus, prostaglandin synthetase inhibitors, vitamin E deficiency, lactic acidosis, prenatal complications, genetic factors) may all be present in an infant."4.76A reexamination of the role of oxygen in retrolental fibroplasia. ( Dangman, B; Lucey, JF, 1984)
"In infants with patent ductus arteriosus, LTV was lower than in controls."2.67Long-term variability of heart rate increases with successful closure of patent ductus arteriosus in preterm infants. ( Maier, R; Obladen, M; Prietsch, V; Schmitz, L, 1992)
"Prenatally diagnosed Ebstein's anomaly with tricuspid valve dysplasia (EA/TVD) is a rare and high-risk congenital heart malformation with limited effective treatments."1.72Treatment of Severe Fetal Ebstein's Anomaly with Prenatal Nonsteroidal Anti-Inflammatory Therapy. ( Kraus, E; Lannaman, K; Powel, JE; Reddy, C, 2022)
" Initial dosing consisted of indomethacin, followed by ibuprofen in most cases."1.62Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly). ( Beroukhim, RS; Cumbermack, KM; Ferrer, Q; Freud, LR; Glickstein, JS; LaFranchi, T; Makhoul, M; Morris, SA; Pedra, SR; Phoon, CK; Sun, HY; Tworetzky, W; Wilkins-Haug, LE, 2021)
"Advancements in the medical treatment of congenital heart disease may create less public acclaim than may surgical treatment but many purely medical developments provide the basis for achieving ultimate surgical success and, by judicious use of some forms of medical treatment, operation can be avoided altogether."1.27Twenty-five years of progress in the medical treatment of pediatric and congenital heart disease. ( McNamara, DG, 1983)

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-199023 (65.71)18.7374
1990's5 (14.29)18.2507
2000's3 (8.57)29.6817
2010's0 (0.00)24.3611
2020's4 (11.43)2.80

Authors

AuthorsStudies
Powel, JE1
Kraus, E1
Reddy, C1
Lannaman, K1
Marini, D1
Xu, J1
Sun, L1
Jaeggi, E1
Seed, M1
Hunter, L1
Vigneswaran, TV1
Pasupathy, D1
Callaghan, N1
Tenenbaum, J1
Zidere, V1
Simpson, JM1
Freud, LR1
Wilkins-Haug, LE1
Beroukhim, RS1
LaFranchi, T1
Phoon, CK1
Glickstein, JS1
Cumbermack, KM1
Makhoul, M1
Morris, SA1
Sun, HY1
Ferrer, Q1
Pedra, SR1
Tworetzky, W1
Watanabe, K1
Tomita, H1
Ono, Y1
Yamada, O1
Kurosaki, K1
Echigo, S1
Kawata, H1
Kishimoto, H1
Miura, T1
Nakajima, T1
Kitajima, H1
Distefano, G1
McNamara, DG1
Drummond, WH1
Bucciarelli, RL1
Gessner, IH1
Gracián Gómez, M1
Rodríguez Caamaño, J1
Guía Torrent, JM1
Lucey, JF1
Dangman, B1
Olley, PM1
Coceani, F1
Rowe, RD1
Swyer, PR1
Strauss, A1
Modanlou, HD1
Gyepes, M1
Wittner, R1
Taylor, WJ1
Alpert, BS1
Heymann, MA5
Rudolph, AM2
Sharykin, AS1
Mogilner, BM1
Ashkenazy, M1
Borenstein, R1
Lancet, M1
Clyman, RI1
Sabik, JF1
Heinemann, MK1
Assad, RS1
Hanley, FL1
Elliott, RB1
Starling, MB1
Neutze, JM1
Levin, DL1
Mills, LJ1
Weinberg, AG1
Gong, G1
Prietsch, V1
Maier, R1
Schmitz, L1
Obladen, M1
Tulzer, G1
Gudmundsson, S1
Sharkey, AM1
Wood, DC1
Cohen, AW1
Huhta, JC1
Menahem, S1
Faist, E1
Ertel, W1
Salmen, B1
Weiler, A1
Ressel, C1
Bolla, K1
Heberer, G1
Gittenberger-de Groot, AC1
Strengers, JL1
Gersony, WM1
Maragno, I1
Alitto, F1
Santostasi, G1
Sandri, R1
Neri, G1
Dorigo, P1
Silove, ED1
Honda, S1
Sandor, GG1

Reviews

12 reviews available for indomethacin and Abnormality, Heart

ArticleYear
Current and future role of fetal cardiovascular MRI in the setting of fetal cardiac interventions.
    Prenatal diagnosis, 2020, Volume: 40, Issue:1

    Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Atrial Septum; Blood Transfusion, Intrauterine; Duc

2020
[The pharmacological manipulation of Botallo's duct in the duct-dependent congenital cardiopathies and in the preterm infants with respiratory distress. A review and personal findings].
    Minerva pediatrica, 2005, Volume: 57, Issue:1

    Topics: Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Agents; Cerebral Angiography; C

2005
The ductus arteriosus: why and how to manipulate its patency.
    The Journal of the Florida Medical Association, 1983, Volume: 70, Issue:9

    Topics: Alprostadil; Ductus Arteriosus, Patent; Gestational Age; Heart Defects, Congenital; Humans; Indometh

1983
[Recent advances and future perspectives in the medical treatment of cardiopathies in children].
    Revista espanola de cardiologia, 1984, Volume: 37 Suppl 1

    Topics: Child; Ductus Arteriosus, Patent; Heart Defects, Congenital; Heart Failure; Humans; Hypoxia; Indomet

1984
A reexamination of the role of oxygen in retrolental fibroplasia.
    Pediatrics, 1984, Volume: 73, Issue:1

    Topics: Anencephaly; Apnea; Carbon Dioxide; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Exchange Transfu

1984
Neonatal manipulation: patent ductus arteriosus.
    Cardiovascular clinics, 1981, Volume: 11, Issue:2

    Topics: Animals; Aorta, Thoracic; Ductus Arteriosus, Patent; Heart Defects, Congenital; Heart Ventricles; Hu

1981
[Prostaglandins and the treatment of congenital heart defects].
    Pediatriia, 1981, Issue:3

    Topics: Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Indomethacin; Infant; Infant, Newborn;

1981
Arachidonic acid derivatives in the perinatal period.
    Advances in pediatrics, 1989, Volume: 36

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Female; Heart Defects, Congenital; Humans; Indomethaci

1989
Prostaglandins and leukotrienes in the perinatal period.
    Clinics in perinatology, 1987, Volume: 14, Issue:4

    Topics: Ductus Arteriosus; Female; Heart Defects, Congenital; Humans; Indomethacin; Infant, Newborn; Leukotr

1987
Patent ductus arteriosus in the neonate.
    Pediatric clinics of North America, 1986, Volume: 33, Issue:3

    Topics: Alprostadil; Blood Circulation; Clinical Trials as Topic; Digoxin; Ductus Arteriosus; Ductus Arterio

1986
[Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application to the pediatric field--arteries and prostaglandins].
    Nihon rinsho. Japanese journal of clinical medicine, 1985, Volume: 43, Issue:3

    Topics: Age Factors; Animals; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Indomethacin; In

1985
Cardiovascular therapy in the newborn.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1985, Volume: 8, Issue:4

    Topics: Digoxin; Dopamine; Ductus Arteriosus; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans;

1985

Trials

4 trials available for indomethacin and Abnormality, Heart

ArticleYear
Intravenous indomethacin therapy in infants with a patent ductus arteriosus complicating other congenital heart defects.
    Circulation journal : official journal of the Japanese Circulation Society, 2003, Volume: 67, Issue:9

    Topics: Cardiovascular Agents; Ductus Arteriosus, Patent; Echocardiography; Female; Heart Defects, Congenita

2003
Long-term variability of heart rate increases with successful closure of patent ductus arteriosus in preterm infants.
    Biology of the neonate, 1992, Volume: 61, Issue:3

    Topics: Alprostadil; Ductus Arteriosus, Patent; Female; Heart Defects, Congenital; Heart Rate; Humans; Indom

1992
The immune-enhancing effect of perioperative thymopentin administration in elderly patients undergoing major surgery.
    Archives of surgery (Chicago, Ill. : 1960), 1988, Volume: 123, Issue:12

    Topics: Adjuvants, Immunologic; Aged; Cardiopulmonary Bypass; Clinical Trials as Topic; Drug Hypersensitivit

1988
Patent ductus arteriosus in the neonate.
    Pediatric clinics of North America, 1986, Volume: 33, Issue:3

    Topics: Alprostadil; Blood Circulation; Clinical Trials as Topic; Digoxin; Ductus Arteriosus; Ductus Arterio

1986

Other Studies

20 other studies available for indomethacin and Abnormality, Heart

ArticleYear
Treatment of Severe Fetal Ebstein's Anomaly with Prenatal Nonsteroidal Anti-Inflammatory Therapy.
    Fetal diagnosis and therapy, 2022, Volume: 49, Issue:5-6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Ebstein Anomaly; Female; Fetal Diseases; Heart Defects, Con

2022
Effects and side effects of maternal administration of indomethacin for fetal tricuspid valve dysplasia.
    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2021, Volume: 58, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Gestational Age; Heart Defects, Congenital;

2021
Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly).
    The American journal of cardiology, 2021, 02-15, Volume: 141

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Constriction; Ductus Arteriosus; Duration of Therapy; Ebste

2021
Surgical management of congenital cardiac defects in neonates and young infants born with extremely low weight.
    Cardiology in the young, 2003, Volume: 13, Issue:4

    Topics: Alprostadil; Cardiac Surgical Procedures; Catecholamines; Ductus Arteriosus, Patent; Heart Defects,

2003
Twenty-five years of progress in the medical treatment of pediatric and congenital heart disease.
    Journal of the American College of Cardiology, 1983, Volume: 1, Issue:1

    Topics: Adrenergic beta-Antagonists; Alprostadil; Cardiac Catheterization; Cardiology; Child; Echocardiograp

1983
Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 7

    Topics: Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Indomethaci

1980
Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant.
    American journal of diseases of children (1960), 1982, Volume: 136, Issue:10

    Topics: Alprostadil; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Hypoxia; Indomethacin; In

1982
Prostaglandins and the management of congenital heart disease.
    American family physician, 1982, Volume: 26, Issue:6

    Topics: Age Factors; Alprostadil; Cardiovascular Diseases; Central Nervous System Diseases; Ductus Arteriosu

1982
Hydrops fetalis caused by maternal indomethacin treatment.
    Acta obstetricia et gynecologica Scandinavica, 1982, Volume: 61, Issue:2

    Topics: Adult; Diseases in Twins; Edema; Female; Heart Defects, Congenital; Humans; Indomethacin; Infant, Ne

1982
Pharmacology of the ductus arteriosus.
    Pediatric clinics of North America, 1981, Volume: 28, Issue:1

    Topics: Animals; Aorta, Thoracic; Cattle; Ductus Arteriosus; Ductus Arteriosus, Patent; Gestational Age; Hea

1981
High-dose steroids prevent placental dysfunction after fetal cardiac bypass.
    The Journal of thoracic and cardiovascular surgery, 1994, Volume: 107, Issue:1

    Topics: Animals; Bicarbonates; Blood Flow Velocity; Carbon Dioxide; Cardiac Output; Cardiopulmonary Bypass;

1994
Medical manipulation of the ductus arteriosus.
    Lancet (London, England), 1975, Jan-18, Volume: 1, Issue:7899

    Topics: Blood Pressure; Ductus Arteriosus; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Ind

1975
Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. A possible mechanism for persistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infant.
    Circulation, 1979, Volume: 60, Issue:2

    Topics: Animals; Blood Pressure; Blood Vessels; Constriction, Pathologic; Ductus Arteriosus; Fetal Heart; He

1979
Medical treatment of the ductus arteriosus.
    Hospital practice, 1977, Volume: 12, Issue:2

    Topics: Animals; Aspirin; Coronary Circulation; Ductus Arteriosus; Ductus Arteriosus, Patent; Fetal Heart; F

1977
[The effect of open heart surgery on human cellular immunological function].
    Zhonghua xin xue guan bing za zhi, 1992, Volume: 20, Issue:4

    Topics: Adolescent; Cardiopulmonary Bypass; Child; Child, Preschool; Heart Defects, Congenital; Humans; Indo

1992
Doppler echocardiography of fetal ductus arteriosus constriction versus increased right ventricular output.
    Journal of the American College of Cardiology, 1991, Volume: 18, Issue:2

    Topics: Blood Flow Velocity; Ductus Arteriosus; Echocardiography, Doppler; Female; Fetal Heart; Gestational

1991
Prostaglandin inhibitors during pregnancy and the effect on the fetus.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1991, Volume: 31, Issue:2

    Topics: Abnormalities, Drug-Induced; Heart Defects, Congenital; Humans; Indomethacin; Infant, Newborn; Mefen

1991
Histopathology of the arterial duct (ductus arteriosus) with and without treatment with prostaglandin E1.
    International journal of cardiology, 1988, Volume: 19, Issue:2

    Topics: Alprostadil; Ductus Arteriosus; Ductus Arteriosus, Patent; Heart Defects, Congenital; Humans; Indome

1988
[Prostaglandins and the perinatal period].
    Minerva cardioangiologica, 1987, Volume: 35, Issue:4

    Topics: Blood Pressure; Blood Vessels; Ductus Arteriosus; Ductus Arteriosus, Patent; Fetus; Heart Defects, C

1987
Pharmacological manipulation of the ductus arteriosus.
    Archives of disease in childhood, 1986, Volume: 61, Issue:9

    Topics: Drug Administration Schedule; Ductus Arteriosus; Ductus Arteriosus, Patent; Heart Defects, Congenita

1986